Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates

Fabrice Graf, Nicola Baker, Jane C. Munday, Harry P. de Koning, David Horn, Pascal Mäser

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)

Abstract

Aquaglyceroporin-2 is a known determinant of melarsoprol-pentamidine cross-resistance in Trypanosoma brucei brucei laboratory strains. Recently, chimerization at the AQP2-AQP3 tandem locus was described from melarsoprol-pentamidine cross-resistant Trypanosoma brucei gambiense isolates from sleeping sickness patients in the Democratic Republic of the Congo. Here, we demonstrate that reintroduction of wild-type AQP2 into one of these isolates fully restores drug susceptibility while expression of the chimeric AQP2/3 gene in aqp2-aqp3 null T. b. brucei does not. This proves that AQP2-AQP3 chimerization is the cause of melarsoprol-pentamidine cross-resistance in the T. b. gambiense isolates.
Original languageEnglish
Pages (from-to)65-68
Number of pages4
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume5
Issue number2
DOIs
Publication statusPublished - 1 Aug 2015
Externally publishedYes

Keywords

  • Aquaporin
  • Drug resistance
  • Human African trypanosomiasis
  • Melarsoprol
  • Pentamidine
  • Reverse genetics
  • Sleeping sickness
  • Trypanosoma brucei gambiense

Fingerprint

Dive into the research topics of 'Chimerization at the AQP2-AQP3 locus is the genetic basis of melarsoprol-pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates'. Together they form a unique fingerprint.

Cite this